The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshops in 2024

Save the date for the CDDF Multi-Stakeholder workshops in 2024!

CANCER DRUG DEVELOPMENT FORUM

The leading non-competitive drug development platform working to
stimulate the advancement and accessibility of cancer treatment.

[ 🔔 📣 NEW PUBLICATION: EXECUTIVE SUMMARY OF THE CDDF ANNUAL CONFERENCE 2024] The Cancer Drug Development Forum (CDDF) is delighted to announced that its executive summary of this year’s Annual Conference has been published today and is available to all our...

Key Takeaways from the CDDF Webinar on Clinical Research in Central and Eastern Europe

The Cancer Drug Development Forum (CDDF) held a live webinar on “Clinical Research in Central and Eastern Europe, Realising the opportunities “ on Monday 12 February 2024 at 17:00 (CET) / 11:00 (EST). In this webinar, Susan Bhatti (Merck BV, NL), Mark Lawler (Queen’s...

CDDF Annual Conference 2024 – Key Takeaways from Session 3: Decentralized Care and Trials

The second day of the CDDF Annual Conference 2024 brought multi-stakeholder speakers and audience together to facilitate candid dialogue on important topics in oncology. Here are the key takeaways from Session 3: Decentralized Care and Trials: 🔶 The Covid-19 pandemic...

CDDF Annual Conference 2024 – Key Takeaways from Session 1: Real World Evidence

The first day of the CDDF Annual Conference 2024 generated highly productive and vibrant dialogue around critical questions about real world evidence and underscoring the importance of collaborative efforts. Here are the key takeaways from Session 1: Real World...

Key Takeaways from the CDDF Webinar on COVID-19 and Cancer – Time for a Reset to Repair the Damage Done

The Cancer Drug Development Forum (CDDF) held a live webinar on “COVID-19 and Cancer – Time for a Reset to repair the damage done “ on Monday 15 January 2024 at 17:00 (CET) / 11:00 (EST). In this webinar,  Mark Lawler (Queen’s University Belfast & CDDF), Ajay...

The CDDF Engages at the Accelerating Global Health Equity Annual Summit

Dr. Catarina Edfjäll, representing the CDDF, participated in a panel discussion on EU Pharmaceutical Legislation at the Accelerating Global Health Equity Annual Summit, held as a World Economic Forum (WEF) side event in Davos on January 18, 2024. Dr. Edfjäll joined...

CDDF’s Selection As Ad Hoc Representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) Under the Accelerating Clinical Trials in the EU (ACT EU)

The Cancer Drug Development Forum is proud to announce its selection as an ad hoc representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) under the Accelerating Clinical Trials in the EU (ACT EU). The ACT EU initiative is run by  the European...

Gain valuable perspectives from CDDF participants and get an inside look at the CDDF Multi-stakeholder workshop on Biomarkers in Precision Oncology (Nov 2023)

Take a look at the interviews with participants from the CDDF Multi-stakeholder Workshop on “Biomarkers in Delivering Drug Development-Related Precision Oncology  (13-14 November 2023, Amsterdam) and gain valuable perspectives from diverse stakeholders. Collaboration...

NEW PUBLICATION-WHITE PAPER: Histology Independent Drug Development – Is This the Future for Cancer Drugs?

The Cancer Drug Development Forum (CDDF) is delighted to announce that the White Paper has been developed following its ‘Histology Independent Drug Development – Is This the Future for Cancer Drugs?’ workshop, which took place on 14-15th November 2022, in Amsterdam....

CDDF’s New Board Members: A Warm Welcome to Dr. Christian Schneider, Dr. Fergus Sweeney and Dr. Rosa Giuliani

With great pleasure, the Cancer Drug Development Forum (CDDF) announces the appointment of Dr. Christian Schneider, Dr. Fergus Sweeney, and Dr. Rosa Giuliani to its Board of Directors for a three-year term, effective 5 December, 2023. We warmly welcome these new...

CDDF Webinar: COVID-19 and Cancer – Time for a Reset to Repair the Damage Done (Jan 2024)

The recording of the recent CDDF webinar on COVID-19 and Cancer – Time for a Reset to Repair the Damage Done is available here. Enjoy the insightful talks from Mark Lawler (Queen’s University Belfast; CDDF Board Member, UK), Ajay Aggarwal (The London School of Hygiene and Tropical Medicine, UK) and Debbie Keatley (Cancer Research UK) followed by a Q&A session.

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here

 

Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70